Viva Bio and BioMap Form AI Biologic Drug Discovery Collaboration

http://www.google.com/cse?cx=008861824939623701802%3Ai1f4t5wyeyi&ie=UTF-8&sa=Search&siteurl=www.chinabiotoday.com%2Fcategories%2F20091030_2&q=viva Viva Biotech, a Shanghai drug discovery CRO, announced a strategic collaboration with Beijing 's BioMap, which offers AI + biological computing services. BioMap was formed in September 2020 by Baidu Ventures, with BV's Chief Executive Liu Wei serving as CEO, and Baidu's founder Robin Li as Chairman. The combination of Viva's structure-based drug discovery technology and BioMap's deep-learning AI platform is expected to accelerate novel drug R&D. More details.... Stock Symbol: (HK: 1873) Share this with colleagues: // //